Clinical Trial Update: Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Sacituzumab Govitecan to physician's choice in endometrial cancer after platinum-based chemotherapy and immunotherapy is ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)

Snippet

Sponsor: Gilead Sciences | Conditions: Endometrial Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING